Gene Therapy
AVI BioPharma Announces Close of Ercole Biotech Acquisition
Published in Gene Therapy Weekly, April 10th, 2008
Under the terms of the agreement, AVI is issuing $7.4 million in AVI common stock valued at $1.3161 per share in exchange for all outstanding shares of Ercole stock not already owned by AVI. In addition, AVI has assumed responsibility for $1.5 million in liabilities of Ercole, to be paid by a combination of cash and AVI stock.
The Importance of RNA Splicing
Through the Human Genome Project and subsequent studies, the way in which the body controls cellular processes has...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2008-04-10)
More Articles from Gene Therapy Weekly
- Macular Degeneration
UK physician revolutionizes gene research - Apoptosis
Study data from Seoul National University, Medical Department update understanding of apoptosis - Atherosclerosis
Research from R.N. Hasan et al has provided new information about atherosclerosis - Bioengineering
New bioengineering study findings have been reported by researchers at Children's Hospital - Biomaterials
Study data from P.W. Lee et al provide new insights into biomaterials - Bladder Cancer
Study results from Medical University of South Carolina update understanding of bladder cancer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
